Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Valvular Heart Disease

  Free Subscription


Articles published in Am Heart J

Retrieve available abstracts of 37 articles:
HTML format
Text format



Single Articles


    July 2017
  1. VEMULAPALLI S, Lippmann SJ, Krucoff M, Hernandez AF, et al
    Cardiovascular events and hospital resource utilization pre- and post-transcatheter mitral valve repair in high-surgical risk patients.
    Am Heart J. 2017;189:146-157.
    PubMed     Text format     Abstract available


  2. ROGERS T, Torguson R, Bastian R, Corso P, et al
    Feasibility of transcatheter aortic valve replacement in low-risk patients with symptomatic severe aortic stenosis: Rationale and design of the Low Risk TAVR (LRT) study.
    Am Heart J. 2017;189:103-109.
    PubMed     Text format     Abstract available


    June 2017
  3. GOLDBERG SL, Meredith I, Marwick T, Haluska BA, et al
    A randomized double-blind trial of an interventional device treatment of functional mitral regurgitation in patients with symptomatic congestive heart failure-Trial design of the REDUCE FMR study.
    Am Heart J. 2017;188:167-174.
    PubMed     Text format     Abstract available


    May 2017
  4. ARENDT CJ, Hong JH, Daly RC, Scott C, et al
    Time to achieving therapeutic international normalized ratio increases hospital length of stay after heart valve replacement surgery.
    Am Heart J. 2017;187:70-77.
    PubMed     Text format     Abstract available


  5. HO CY, McMurray JJV, Cirino AL, Colan SD, et al
    The Design of the Valsartan for Attenuating Disease Evolution in Early Sarcomeric Hypertrophic Cardiomyopathy (VANISH) Trial.
    Am Heart J. 2017;187:145-155.
    PubMed     Text format     Abstract available


    March 2017
  6. KLECZYNSKI P, Dziewierz A, Bagienski M, Rzeszutko L, et al
    Impact of frailty on mortality after transcatheter aortic valve implantation.
    Am Heart J. 2017;185:52-58.
    PubMed     Text format     Abstract available


    February 2017
  7. MARTIN GP, Sperrin M, Ludman PF, de Belder MA, et al
    Inadequacy of existing clinical prediction models for predicting mortality after transcatheter aortic valve implantation.
    Am Heart J. 2017;184:97-105.
    PubMed     Text format     Abstract available


  8. KOIFMAN E, Didier R, Patel N, Jerusalem Z, et al
    Impact of right ventricular function on outcome of severe aortic stenosis patients undergoing transcatheter aortic valve replacement.
    Am Heart J. 2017;184:141-147.
    PubMed     Text format     Abstract available


  9. SORENSEN LL, Liang HY, Pinheiro A, Hilser A, et al
    Safety profile and utility of treadmill exercise in patients with high-gradient hypertrophic cardiomyopathy.
    Am Heart J. 2017;184:47-54.
    PubMed     Text format     Abstract available


    December 2016
  10. SPITZER E, Van Mieghem NM, Pibarot P, Hahn RT, et al
    Rationale and design of the Transcatheter Aortic Valve Replacement to UNload the Left ventricle in patients with ADvanced heart failure (TAVR UNLOAD) trial.
    Am Heart J. 2016;182:80-88.
    PubMed     Text format     Abstract available


  11. PRESSLER A, Christle JW, Lechner B, Grabs V, et al
    Exercise training improves exercise capacity and quality of life after transcatheter aortic valve implantation: A randomized pilot trial.
    Am Heart J. 2016;182:44-53.
    PubMed     Text format     Abstract available


  12. DAHYA V, Xiao J, Prado CM, Burroughs P, et al
    Computed tomography-derived skeletal muscle index: A novel predictor of frailty and hospital length of stay after transcatheter aortic valve replacement.
    Am Heart J. 2016;182:21-27.
    PubMed     Text format     Abstract available


  13. CHAUHAN D, Haik N, Merlo A, Haik BJ, et al
    Quantitative increase in frailty is associated with diminished survival after transcatheter aortic valve replacement.
    Am Heart J. 2016;182:146-154.
    PubMed     Text format     Abstract available


    October 2016
  14. WINDECKER S, Tijssen J, Giustino G, Guimaraes AH, et al
    Trial design: Rivaroxaban for the prevention of major cardiovascular events after transcatheter aortic valve replacement: Rationale and design of the GALILEO study.
    Am Heart J. 2016;184:81-87.
    PubMed     Text format     Abstract available


  15. VOLLENBROICH R, Stortecky S, Praz F, Lanz J, et al
    The impact of functional vs degenerative mitral regurgitation on clinical outcomes among patients undergoing transcatheter aortic valve implantation.
    Am Heart J. 2016;184:71-80.
    PubMed     Text format     Abstract available


    September 2016
  16. THUNE JJ, Pehrson S, Nielsen JC, Haarbo J, et al
    Rationale, design, and baseline characteristics of the DANish randomized, controlled, multicenter study to assess the efficacy of Implantable cardioverter defibrillators in patients with non-ischemic Systolic Heart failure on mortality (DANISH).
    Am Heart J. 2016;179:136-41.
    PubMed     Text format     Abstract available


    August 2016
  17. BANOVIC M, Iung B, Bartunek J, Penicka M, et al
    Response: Asymptomatic severe aortic stenosis: Cardiopulmonary exercise testing in "the world of AVATAR".
    Am Heart J. 2016;178:e3-4.
    PubMed     Text format    


  18. DOMINGUEZ-RODRIGUEZ A, Abreu-Gonzalez P
    Asymptomatic severe aortic stenosis: Cardiopulmonary exercise testing in "The World of AVATAR".
    Am Heart J. 2016;178:e1.
    PubMed     Text format    


  19. ABATE E, Hoogslag GE, Al Amri I, Debonnaire P, et al
    Time course, predictors, and prognostic implications of significant mitral regurgitation after ST-segment elevation myocardial infarction.
    Am Heart J. 2016;178:115-25.
    PubMed     Text format     Abstract available


  20. KIRAMIJYAN S, Magalhaes MA, Koifman E, Didier R, et al
    Impact of baseline mitral regurgitation on short- and long-term outcomes following transcatheter aortic valve replacement.
    Am Heart J. 2016;178:19-27.
    PubMed     Text format     Abstract available


  21. MARTINS RP, Galand V, Colette E, Behar N, et al
    Defining nonvalvular atrial fibrillation: A quest for clarification.
    Am Heart J. 2016;178:161-7.
    PubMed     Text format     Abstract available


    July 2016
  22. DAYOUB EJ, Nallamothu BK
    Geographic access to transcatheter aortic valve replacement relative to other invasive cardiac services: A statewide analysis.
    Am Heart J. 2016;177:163-70.
    PubMed     Text format     Abstract available


  23. BAKKESTROM R, Larsen LA, Moller JE, Videbaek L, et al
    Mitral valve regurgitation in twins: Concordance and survival.
    Am Heart J. 2016;177:51-7.
    PubMed     Text format     Abstract available


    May 2016
  24. DOBSON LE, Fairbairn TA, Musa TA, Uddin A, et al
    Sex-related differences in left ventricular remodeling in severe aortic stenosis and reverse remodeling after aortic valve replacement: A cardiovascular magnetic resonance study.
    Am Heart J. 2016;175:101-11.
    PubMed     Text format     Abstract available


    April 2016
  25. BANOVIC M, Iung B, Bartunek J, Asanin M, et al
    Rationale and design of the Aortic Valve replAcemenT versus conservative treatment in Asymptomatic seveRe aortic stenosis (AVATAR trial): A randomized multicenter controlled event-driven trial.
    Am Heart J. 2016;174:147-53.
    PubMed     Text format     Abstract available


    March 2016
  26. ESCARCEGA RO, Baker NC, Lipinski MJ, Koifman E, et al
    Clinical profiles and correlates of mortality in nonagenarians with severe aortic stenosis undergoing transcatheter aortic valve replacement.
    Am Heart J. 2016;173:118-25.
    PubMed     Text format     Abstract available


  27. NIJENHUIS VJ, Bennaghmouch N, Hassell M, Baan J Jr, et al
    Rationale and design of POPular-TAVI: antiPlatelet therapy fOr Patients undergoing Transcatheter Aortic Valve Implantation.
    Am Heart J. 2016;173:77-85.
    PubMed     Text format     Abstract available


    February 2016
  28. WANG A, Grayburn P, Foster JA, McCulloch ML, et al
    Practice gaps in the care of mitral valve regurgitation: Insights from the American College of Cardiology mitral regurgitation gap analysis and advisory panel.
    Am Heart J. 2016;172:70-9.
    PubMed     Text format     Abstract available


    November 2015
  29. VELAZQUEZ EJ, Samad Z, Al-Khalidi HR, Sangli C, et al
    The MitraClip and survival in patients with mitral regurgitation at high risk for surgery: A propensity-matched comparison.
    Am Heart J. 2015;170:1050-1059.
    PubMed     Text format     Abstract available


    October 2015
  30. GOTZMANN M, Knoop H, Ewers A, Mugge A, et al
    Impact of lung diseases on morbidity and mortality after transcatheter aortic valve implantation: Insights from spirometry and body plethysmography.
    Am Heart J. 2015;170:837-842.
    PubMed     Text format     Abstract available


  31. SINNING JM, Wollert KC, Sedaghat A, Widera C, et al
    Risk scores and biomarkers for the prediction of 1-year outcome after transcatheter aortic valve replacement.
    Am Heart J. 2015;170:821-9.
    PubMed     Text format     Abstract available


    August 2015
  32. OZKAN M, Gunduz S, Gursoy OM, Karakoyun S, et al
    Ultraslow thrombolytic therapy: A novel strategy in the management of PROsthetic MEchanical valve Thrombosis and the prEdictors of outcomE: The Ultra-slow PROMETEE trial.
    Am Heart J. 2015;170:409-18.
    PubMed     Text format     Abstract available


  33. KRAMER CM, Appelbaum E, Desai MY, Desvigne-Nickens P, et al
    Hypertrophic Cardiomyopathy Registry: The rationale and design of an international, observational study of hypertrophic cardiomyopathy.
    Am Heart J. 2015;170:223-30.
    PubMed     Text format     Abstract available


    July 2015
  34. CAPODANNO D, Adamo M, Barbanti M, Giannini C, et al
    Predictors of clinical outcomes after edge-to-edge percutaneous mitral valve repair.
    Am Heart J. 2015;170:187-95.
    PubMed     Text format     Abstract available


  35. CHRISTODOULIDIS G, Yu J, Kini A, Dangas GD, et al
    Gender-specific outcomes after balloon aortic valvuloplasty: Inhospital and long-term outcomes.
    Am Heart J. 2015;170:180-6.
    PubMed     Text format     Abstract available


  36. PAULEY E, Lishmanov A, Schumann S, Gala GJ, et al
    Delirium is a robust predictor of morbidity and mortality among critically ill patients treated in the cardiac intensive care unit.
    Am Heart J. 2015;170:79-86.
    PubMed     Text format     Abstract available


    May 2015
  37. MASRI A, Pierson LM, Smedira NG, Agarwal S, et al
    Predictors of long-term outcomes in patients with hypertrophic cardiomyopathy undergoing cardiopulmonary stress testing and echocardiography.
    Am Heart J. 2015;169:684-692.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Valvular Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: